Business Context and Reporting Period
Company: Organigram Global Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and nine months ended June 30, 2025
Filing Date: August 13, 2025
Principal Executive Offices: Toronto, Ontario, Canada
This filing serves as a cover document submitting interim financial results and management discussion for the period ended June 30, 2025. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. Detailed metrics including revenue, profit, cash flow, margins, debt, and liquidity are located in the attached exhibits (Exhibit 99.1 and 99.2) but are not present in the source text provided.
- Revenue: Not provided in source text.
- Profit/Loss: Not provided in source text.
- Cash Flow: Not provided in source text.
- Debt and Liquidity: Not provided in source text.
Material Changes
The filing text does not provide specific comparative data or material changes versus prior periods. Investors must refer to the attached Management's Discussion and Analysis (Exhibit 99.1) for year-over-year or quarter-over-quarter comparisons.
Guidance, Outlook, and Risks
The cover document does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These disclosures are expected to be found within the attached News Release (Exhibit 99.5) and MD&A (Exhibit 99.1).
Investor Verification Checklist
- Verify the specific revenue and net income figures in Exhibit 99.2 (Condensed Consolidated Interim Unaudited Financial Statements).
- Review Exhibit 99.1 (MD&A) for explanations of any significant variances from the prior year.
- Check Exhibit 99.5 (News Release) for updated operational guidance and strategic outlook.
- Confirm the status of the company's liquidity and debt covenants in the financial statements.